Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl] methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis

  • D. J. David
  • , K. C. Klemenhagen
  • , K. A. Holick
  • , M. D. Saxe
  • , I. Mendez
  • , L. Santarelli
  • , D. A. Craig
  • , H. Zhong
  • , C. J. Swanson
  • , L. G. Hegde
  • , X. I. Ping
  • , D. Dong
  • , M. R. Marzabadi
  • , C. P. Gerald
  • , René Hen

Research output: Contribution to journal › Article › peer-review

128 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl] methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience